Synemin is expressed in reactive astrocytes and Rosenthal fibers in Alexander disease

Apmis ◽  
2013 ◽  
Vol 122 (1) ◽  
pp. 76-80 ◽  
Author(s):  
Tulen Pekny ◽  
Maryam Faiz ◽  
Ulrika Wilhelmsson ◽  
Maurice A. Curtis ◽  
Radoslav Matej ◽  
...  

Author(s):  
Alexander A. Sosunov ◽  
Guy M. McKhann ◽  
James E. Goldman


1997 ◽  
Vol 56 (5) ◽  
pp. 595
Author(s):  
A. B. Johnson ◽  
K. M. Weidenheim ◽  
L. A. Goodman ◽  
S. J. Horwitz


2021 ◽  
Vol 23 (1) ◽  
pp. 149
Author(s):  
Schuichi Koizumi ◽  
Eiji Shigetomi ◽  
Fumikazu Sano ◽  
Kozo Saito ◽  
Sun Kwang Kim ◽  
...  

In pathological brain conditions, glial cells become reactive and show a variety of responses. We examined Ca2+ signals in pathological brains and found that reactive astrocytes share abnormal Ca2+ signals, even in different types of diseases. In a neuropathic pain model, astrocytes in the primary sensory cortex became reactive and showed frequent Ca2+ signals, resulting in the production of synaptogenic molecules, which led to misconnections of tactile and pain networks in the sensory cortex, thus causing neuropathic pain. In an epileptogenic model, hippocampal astrocytes also became reactive and showed frequent Ca2+ signals. In an Alexander disease (AxD) model, hGFAP-R239H knock-in mice showed accumulation of Rosenthal fibers, a typical pathological marker of AxD, and excessively large Ca2+ signals. Because the abnormal astrocytic Ca2+ signals observed in the above three disease models are dependent on type II inositol 1,4,5-trisphosphate receptors (IP3RII), we reanalyzed these pathological events using IP3RII-deficient mice and found that all abnormal Ca2+ signals and pathologies were markedly reduced. These findings indicate that abnormal Ca2+ signaling is not only a consequence but may also be greatly involved in the cause of these diseases. Abnormal Ca2+ signals in reactive astrocytes may represent an underlying pathology common to multiple diseases.



1997 ◽  
Vol 231 (2) ◽  
pp. 79-82 ◽  
Author(s):  
R.J Castellani ◽  
G Perry ◽  
P.L.R Harris ◽  
V.M Monnier ◽  
M.L Cohen ◽  
...  


2013 ◽  
Vol 33 (17) ◽  
pp. 7439-7450 ◽  
Author(s):  
A. A. Sosunov ◽  
E. Guilfoyle ◽  
X. Wu ◽  
G. M. McKhann ◽  
J. E. Goldman


2016 ◽  
Vol 15 (7) ◽  
pp. 2265-2282 ◽  
Author(s):  
Michael R. Heaven ◽  
Daniel Flint ◽  
Shan M. Randall ◽  
Alexander A. Sosunov ◽  
Landon Wilson ◽  
...  


Author(s):  
Roberta Battini ◽  
Enrico Bertini ◽  
Roberta Milone ◽  
Chiara Aiello ◽  
Rosa Pasquariello ◽  
...  

Abstract PRUNE1-related disorders manifest as severe neurodevelopmental conditions associated with neurodegeneration, implying a differential diagnosis at birth with static encephalopathies, and later with those manifesting progressive brain damage with the involvement of both the central and the peripheral nervous system.Here we report on another patient with PRUNE1 (p.Asp106Asn) recurrent mutation, whose leukodystrophy, inferior olives hyperintensity, and macrocephaly led to the misleading clinical suspicion of Alexander disease. Clinical features, together with other recent descriptions, suggest avoiding the term “microcephaly” in defining this disorder that could be renamed “neurodevelopmental disorder with progressive encephalopathy, hypotonia, and variable brain anomalies” (NPEHBA).



Sign in / Sign up

Export Citation Format

Share Document